These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 29167179)

  • 1. Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases.
    Kawamata H; Manfredi G
    J Cell Biol; 2017 Dec; 216(12):3917-3929. PubMed ID: 29167179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention.
    Briston T; Hicks AR
    Biochem Soc Trans; 2018 Aug; 46(4):829-842. PubMed ID: 29986938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mPOS is a novel mitochondrial trigger of cell death - implications for neurodegeneration.
    Coyne LP; Chen XJ
    FEBS Lett; 2018 Mar; 592(5):759-775. PubMed ID: 29090463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misfolded proteins, mitochondrial dysfunction, and neurodegenerative diseases.
    Reddy PH
    Biochim Biophys Acta; 2014 Aug; 1842(8):1167. PubMed ID: 24686117
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction between pathogenic proteins in neurodegenerative disorders.
    Jellinger KA
    J Cell Mol Med; 2012 Jun; 16(6):1166-83. PubMed ID: 22176890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases.
    Melki R
    J Parkinsons Dis; 2015; 5(2):217-27. PubMed ID: 25757830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the Role of Normal Aging Processes in the Onset and Pathogenesis of Diseases Associated with the Abnormal Accumulation of Protein Aggregates.
    Ilyinsky NS; Nesterov SV; Shestoperova EI; Fonin AV; Uversky VN; Gordeliy VI
    Biochemistry (Mosc); 2021 Mar; 86(3):275-289. PubMed ID: 33838629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramitochondrial proteostasis is directly coupled to α-synuclein and amyloid β1-42 pathologies.
    Lautenschläger J; Wagner-Valladolid S; Stephens AD; Fernández-Villegas A; Hockings C; Mishra A; Manton JD; Fantham MJ; Lu M; Rees EJ; Kaminski CF; Kaminski Schierle GS
    J Biol Chem; 2020 Jul; 295(30):10138-10152. PubMed ID: 32385113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities.
    Schmidt MF; Gan ZY; Komander D; Dewson G
    Cell Death Differ; 2021 Feb; 28(2):570-590. PubMed ID: 33414510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial involvement in neurodegenerative diseases.
    Zsurka G; Kunz WS
    IUBMB Life; 2013 Mar; 65(3):263-72. PubMed ID: 23341346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invited Review: The role of prion-like mechanisms in neurodegenerative diseases.
    Jaunmuktane Z; Brandner S
    Neuropathol Appl Neurobiol; 2020 Oct; 46(6):522-545. PubMed ID: 31868945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial degradation of amyloidogenic proteins - A new perspective for neurodegenerative diseases.
    Lautenschäger J; Kaminski Schierle GS
    Prog Neurobiol; 2019 Oct; 181():101660. PubMed ID: 31301323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and Functions of Spatial Protein Quality Control.
    Sontag EM; Samant RS; Frydman J
    Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-nitrosylation of critical protein thiols mediates protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.
    Nakamura T; Lipton SA
    Antioxid Redox Signal; 2011 Apr; 14(8):1479-92. PubMed ID: 20812868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson's Disease: Roads to Biomarker Discovery.
    Picca A; Guerra F; Calvani R; Romano R; Coelho-Júnior HJ; Bucci C; Marzetti E
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MISTERMINATE Mechanistically Links Mitochondrial Dysfunction with Proteostasis Failure.
    Wu Z; Tantray I; Lim J; Chen S; Li Y; Davis Z; Sitron C; Dong J; Gispert S; Auburger G; Brandman O; Bi X; Snyder M; Lu B
    Mol Cell; 2019 Aug; 75(4):835-848.e8. PubMed ID: 31378462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Walking the tightrope: proteostasis and neurodegenerative disease.
    Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
    J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seeding and propagation of lesions in neurodegenerative diseases: a new paradigm.
    Duyckaerts C; Seilhean D; Sazdovitch V; Plu I; Delatour B; Potier MC
    Bull Acad Natl Med; 2015 Jun; 199(6):809-819. PubMed ID: 29901881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.